• Human APIs PowderRespiratory Drugs Raw Material Antiviral Antibacterial Antipyretic Analgesics Antihistamine Drugs Antineoplastic Cosmetic Raw Material
  • Pharmaceutical IntermediatesPharmaceutical intermediates Nutritional Supplements Pharmaceutical raw materials
  • OEM & ODMCapsule Softgel Capsule Gummies Drop & drinks Tables
  • Veterinary raw materialsAntibacterial anti-inflammatory Respiratory Drugs Anthelmintics Antiviral drugs Feed additives
  • About UsCompany profileQualificationQuality AssuranceService teamFactory TourR&D Center
  • Hrk supply Actinomycin D Raw materials powder

    • Hrk supply Actinomycin D Raw materials powder
    • Hrk supply Actinomycin D Raw materials powder storehouse
    • Hrk supply Actinomycin D Raw materials powder quality testing
    • Hrk supply Actinomycin D Raw materials powder quality testing
    • Hrk supply Actinomycin D Raw materials powder certificate

    Product Overview:

    Actinomycin D (Dactinomycin) is an organic compound with the chemical formula C62H86N12O16. It is a bright red crystalline powder, insoluble in petroleum ether, slightly soluble in water, soluble in methanol, ethanol and ethyl acetate, easily soluble in benzene, chloroform and acetone.
    Actinomycin D can inhibit the synthesis of RNA and interfere with the transcription process of cells by acting on mRNA. After intravenous injection, it quickly disappears from the blood, within 24 hours, 12% to 25% is excreted by the kidney, and 50% to 90% is excreted by the bile. In combination with radiation, the sensitivity of the tumor to radiation can be increased.

    Hrk supply Actinomycin D Raw materials powder Attributes

    Natural Actinomycin D Raw materials powder

    CAS:50-76-0

    MF:C62H86N12O16

    Actinomycin D

    MW:1255.42

    EINECS:200-063-6

    Specification: 99% min Actinomycin D powder

    Sample:Actinomycin D powder

    Packaging:1kg/bag, 25kg/drum

    Brand: Raw materials

    Appearance:red

    Storage: Store at -20°C

    Shelf Life: 2 Years

    Test Method: HPLC

    Hrk supply Actinomycin D Raw materials powder Details

    Actinomycin D powder Classification.

    Hodgkin's disease (‌HD) ‌ : ‌ actinomycin D has outstanding efficacy in the treatment of Hodgkin's disease, ‌ especially in the control of fever. ‌

    Neuroblastoma: ‌ Similarly, ‌ actinomycin D has shown remarkable efficacy in the treatment of neuroblastoma. ‌

    Choriocarcinoma without metastasis: ‌ For the primary treatment of choriocarcinoma without metastasis, the cure rate of ‌ with actinomycin D alone is 90% to 100%, and the effect of ‌ is similar to that of MTX alone. ‌

    Testicular cancer: ‌ actinomycin D is also used in the treatment of testicular cancer, ‌ is often used in combination with other drugs. ‌

    Pediatric nephroblastoma (‌Wilms tumor) ‌ : ‌ When used in combination with radiotherapy, ‌ improves survival. ‌ is also effective for Youwen's sarcoma and rhabdomyosarcoma. ‌

    Actinomycin D powder

    Uses of Actinomycin D.

    Actinomycin D is extracted from a kind of actinomycetes isolated from soil after fermentation. In vitro studies have shown that actinomyctin D mainly acts on RNA, and at high concentrations, it affects RNA and DNA synthesis at the same time. The mechanism of action is that it is chimeric in the DNA double strand and binds to its guanine group, inhibits the DNA-dependent RNA polymerase activity, interferes with the transcription process of cells, and thus inhibits mRNA synthesis, that is, it can interfere with the transcription process of mRNA cells in human body, and has therapeutic effects on nerve and nephroblastoma, rhabdomyosarcoma, Hodgkin's disease and testicular tumor, etc. It can also be treated with actinomycin D.

    Actinomycin D

    Preparation of Actinomycin D.

    Product Methods of Bulk Actinomycin D powder.

    Our advantage
    Our Factory
    Shipping
    Tel: 86-29-89601602
    WhatsApp: 8615091775531
    WeChat: 15091775531
    E-mail: sales21@interlgroup.com
    Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
    ©2023 Xi'an Henrikang Biotech Co., Ltd.,